Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance

BACKGROUND: Mortality rates for patients with Staphylococcus aureus (S. aureus) infections have improved only modestly in recent decades and S. aureus infections remain a major clinical challenge This study investigated the in vitro antimicrobial activity of erevacycline (erava) against clinical S....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Bai, Bing, Xu, Guang-jian, Lin, Zhi-wei, Li, Gui-qiu, Chen, Zhong, Cheng, Hang, Sun, Xiang, Wang, Hong-yan, Chen, Yan-wei, Zheng, Jin-xin, Deng, Qi-wen, Yu, Zhi-jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293590/
https://www.ncbi.nlm.nih.gov/pubmed/30545293
http://dx.doi.org/10.1186/s12866-018-1349-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293590/
https://www.ncbi.nlm.nih.gov/pubmed/30545293
http://dx.doi.org/10.1186/s12866-018-1349-7

Ejemplares similares